In a landmark decision, the National Pharmaceutical Pricing Authority (NPPA) has hiked the ceiling price of 21 medicines by 50 percent.
The move is expected to make medicines available as companies faced a rise in prices of active pharmaceutical ingredients (APIs), a major raw material.
Sakshi Batra does a 3-Point Analysis to find out how investors should read this development.
Watch the video for more.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
